Papers
1
Total Citations
4
H-Index
1
About
Dr. Qinbo Wang is a pioneering surgical oncologist whose research focuses on advancing minimally invasive techniques for breast cancer management, particularly through robotic-assisted surgery and innovative lymphatic mapping. His most impactful work centers on improving sentinel lymph node biopsy (SLNB) accuracy—a critical procedure for staging breast cancer. In a landmark 2025 study, Dr. Wang demonstrated that combining indocyanine green with carbon nanoparticle staining during robot-assisted SLNB significantly enhanced detection rates compared to conventional methods. This dual-tracer approach, tested in 52 patients, proved both safe and highly effective, offering a more precise, less invasive alternative for nodal staging. With 4 citations already, this work is gaining traction as a potential new standard. Dr. Wang’s contributions bridge robotics and nanotechnology, directly addressing the clinical challenge of reducing false-negative rates in breast cancer surgery. His research not only refines surgical precision but also minimizes patient morbidity, showcasing his commitment to translating cutting-edge technology into tangible clinical benefits. For students and researchers, Dr. Wang exemplifies how integrating novel tracers with robotic platforms can push the boundaries of oncologic surgery.
Research Focus
Key Achievements
Top Papers
- 1